Skip to main content

Legacy 30-day mortality post-Systemic Anti-Cancer Therapy - Case-Mix Adjusted Rates

This is the archived version of the 30-day mortality post-Systemic Anti-Cancer Therapy (SACT) case-mix adjusted rates (CMAR) reports.

Please note this is a historic project conducted when NDRS was situated in Public Health England (PHE). This content will not be updated.

You can contact the team at [email protected] if you have any questions.

View the latest version of this dashboard. 

OPEN DASHBOARD 

(Please note both links open in a new window)

Example of legacy CMAR dashboard

Introduction

The CMAR reports show rates of deaths within 30 days of SACT treatment, adjusted for key patient factors. Overall 30-day mortality rates are presented for each NHS trust identified as treating patients diagnosed with the defined cancer type with SACT within the defined treatment period. 

Last edited: 14 November 2024 8:39 am